A leap in the dark: Bariatric surgery for treatment of metabolic dysfunction-associated steatotic liver disease related cirrhosis: Editorial on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”

Ähnliche Einträge

• A leap in the dark: Bariatric surgery for treatment of metabolic dysfunction-associated steatotic liver disease related cirrhosis: Editorial on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”
  von: Jing Zeng, et al.
  Veröffentlicht: (2025-04-01)
• Letter to the editor on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”
  von: Weixiong Zhu, et al.
  Veröffentlicht: (2025-07-01)
• Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis
  von: Nicholas A. Rouillard, et al.
  Veröffentlicht: (2025-01-01)
• Correspondence to editorial on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”
  von: Nicholas A. Rouillard, et al.
  Veröffentlicht: (2025-04-01)
• Letter to the editor on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”
  von: Chi-Kuei Hsu, et al.
  Veröffentlicht: (2025-07-01)